Medical Devices
Endocrine Testing Market

Endocrine Testing Market Size, Share, Trends, and Growth Forecast 2025 - 2032

Endocrine Testing Market by Test (Testosterone Test, Endocrine Test, Others), by Technology (Immunoassay, Tandem Mass Spectrometry, Others), by Disease Indication (Diabetes, Hyperthyroidism), by End-use, by Regional Analysis 2025 - 2032

ID: PMRREP35201

April 2025

180 Pages

Author : Abhijeet Surwase

Healthcare

Market Dynamics

Driver - Growing Awareness and Early Prognosis Boosts Need for Testing Kits

Increasing awareness and early diagnosis are key drivers of the endocrine testing market as proactive health monitoring becomes more common. The World Health Organization (WHO) estimates that over 422 million people worldwide have diabetes, highlighting the urgent need for early detection.

Public health initiatives and awareness campaigns are encouraging routine screening for thyroid disorders, adrenal dysfunction, and hormonal imbalances. Additionally, advancements in home-based test kits and point-of-care diagnostics have made early detection more accessible. The rising demand for preventive healthcare and self-monitoring solutions is accelerating market growth, ensuring timely intervention and improved patient outcomes for endocrine disorders.

Restraint - High Testing Costs and Limited Access in Low-Income Regions

Despite promising growth, the market faces challenges due to the high costs associated with advanced diagnostic tools and testing procedures. Several hormone tests require specialized equipment, trained professionals, and ongoing maintenance, which can be financially burdening for smaller clinics and hospitals. This is particularly problematic in low- and middle-income countries, where the healthcare infrastructure is underdeveloped and affordability is a concern. Additionally, limited awareness and lack of routine screening programs in rural areas hinder early diagnosis and treatment. Reimbursement issues and regulatory hurdles also impact market adoption. These factors collectively restrain the widespread implementation of endocrine testing, slowing market growth despite increasing global demand.

Opportunity - Rising Prevalence of Hormonal Disorders Fuels the Need for TSH Tests

The increasing incidence of endocrine-related disorders such as diabetes, thyroid dysfunction, and adrenal imbalances presents a major opportunity in the endocrine testing market. The need for accurate, early diagnostic testing is growing with lifestyle changes, aging populations, and heightened stress levels contributing to hormonal imbalances. Additionally, improved access to healthcare services and greater public awareness of endocrine health encourage routine screening and testing. Technological advancements, such as point-of-care testing and highly sensitive assays, are making endocrine tests more efficient and accessible. Moreover, the expansion of personalized medicine and preventive healthcare is further boosting demand for regular endocrine function assessments, creating significant opportunities for diagnostic laboratories and healthcare providers globally.

Get Your CustomizationGet Your Customization

Category-Wise Insights

Test Insights

Thyroid Stimulating Hormone (TSH) is the leading test category in the global market and is projected to account for 29.4% share in 2025. The growing incidence of thyroid disorders and the increasing emphasis on early diagnosis are key factors driving the demand for TSH tests. These tests are essential for evaluating thyroid function as they measure the levels of thyroid-stimulating hormone, which regulates the production of thyroid hormones. Proper thyroid function is crucial for metabolism, energy levels, and overall hormonal balance.

Medical studies have highlighted the role of TSH in immune regulation and its influence on maintaining hormonal stability, including progesterone and human chorionic gonadotropin (hCG). With thyroid-related conditions becoming more prevalent, TSH tests have become a standard diagnostic tool for identifying and monitoring conditions such as hypothyroidism and hyperthyroidism. Additionally, advancements in laboratory automation and the availability of high-sensitivity TSH assays have improved testing accuracy and accessibility. As awareness of thyroid health continues to rise, the adoption of TSH tests is expected to grow further in both clinical and home testing settings.

Technology Insights

Tandem mass spectrometry (MS/MS) is gaining widespread adoption in endocrine testing due to its superior analytical capabilities. Technology is often paired with liquid chromatography, ensuring precise and reliable hormone measurement. Its high sensitivity and specificity allow for the simultaneous detection of multiple analytes, making it a preferred method for complex endocrine assessments.

The increasing need for accuracy in hormone analysis has led laboratories and healthcare institutions to integrate MS/MS into routine diagnostic procedures. Unlike traditional immunoassays, which may present cross-reactivity issues, tandem mass spectrometry minimizes interference and provides consistent results. This advancement is particularly beneficial for detecting low-abundance hormones and monitoring endocrine disorders such as adrenal insufficiency and congenital adrenal hyperplasia.

endocrine testing market insights and key trends

Regional Insights and Trends

North America Endocrine Testing Market Trends

?The North American endocrine testing market is experiencing significant growth, driven by the rising prevalence of hormone-related disorders, particularly thyroid cancer. The American Cancer Society estimates that in 2025, there will be about 44,020 new cases of thyroid cancer in the U.S., with 12,670 in men and 31,350 in women, and approximately 2,290 deaths from the disease.

Advancements in diagnostic technologies, such as automated platforms and multiplex assays, are enhancing the accuracy and efficiency of endocrine testing. The increasing adoption of point-of-care and at-home testing kits improves accessibility for patients. Furthermore, collaborations between healthcare providers and diagnostic companies are expanding testing services, particularly in underserved areas. As healthcare awareness grows and technology advances, the North American endocrine testing market is poised for continued expansion to meet the evolving needs of the population.

Europe Endocrine Testing Market Trends

The prevalence of overweight and obesity in Europe has seen a significant rise over the past decades. According to the Organization for Economic Co-operation and Development (OECD) projections, by 2030, over half of Europe’s population could be affected by obesity, with rates reaching up to 89% in some countries. The growing incidence of obesity is closely linked to a surge in endocrine disorders, including diabetes and thyroid dysfunction, thereby amplifying the demand for endocrine testing services.?

Furthermore, increased health awareness among European population has led to a higher uptake of routine endocrine screenings. Healthcare providers are emphasizing early detection and managing hormone-related disorders, contributing to the market's expansion. Collaborations between diagnostic companies and healthcare institutions foster development of innovative testing solutions tailored to the region's specific needs.

Asia Pacific Endocrine Testing Market Trends

Asia Pacific is expected to witness fast-growth driven by increasing healthcare reforms, urbanization, and economic expansion. Established players are expanding their regional footprint, further boosting market growth.

China's endocrine testing market is expanding due to rising cases of diabetes, thyroid disorders, and obesity-related hormonal imbalances. According to the International Diabetes Federation, China had approximately 140 million adults living with diabetes in 2023, the highest number globally. Increased awareness of hormonal disorders and government initiatives promoting preventive healthcare have further fueled market demand.

MEA Endocrine Testing Market Trends

?MEA endocrine testing market is witnessing robust growth due to rising lifestyle disorders, medical tourism, and expanding healthcare investments. The region's medical tourism boom is further fueling demand for advanced diagnostic services. In 2023, Dubai attracted over 691,000 international medical tourists, generating AED 1.03 billion in healthcare spending, highlighting the region’s appeal for specialized treatments, including endocrine testing.

MEA governments are investing in laboratory automation, biomarker research, and AI-powered diagnostics, enhancing accuracy and accessibility. Point-of-care testing (POCT) is expanding, particularly in remote areas. Growing private-sector collaborations and rising demand for preventive healthcare is driving market growth.

LATAM Endocrine Testing Market Trends

?The Latin America (LATAM) endocrine testing market is expanding due to rising diabetes and obesity rates and increasing demand for hormone disorder diagnostics. According to the IDF, over 32 million adults in LATAM had diabetes in 2023, fueling the need for early detection. Government initiatives promoting preventive healthcare and affordable diagnostic solutions are further driving market growth. Additionally, the booming medical tourism sector in Brazil and Mexico is boosting demand for advanced endocrine testing services.

Request Free sampleRequest Free sample

Competitive Landscape

The global endocrine testing market is highly competitive. Major players focus on innovation and strategic collaborations to maintain their competitive edge. Companies are heavily investing in research and development to introduce advanced testing solutions, incorporating automated laboratory processes, next-generation testing platforms, and multiplex testing capabilities.

In addition, partnerships with healthcare providers are expanding access to endocrine testing in emerging markets. Compliance with regulatory standards and adherence to international quality guidelines remain essential, allowing companies to meet the rising demand for reliable and efficient endocrine testing devices.

Key Industry Developments

In March 2025, London-based HealthTech startup Level Zero Health secured US$ 8.4 mn pre-seed funding round to advance remote and continuous hormone monitoring through DNA-based sensor technology.
In January 2025, Eli Health launched the Hormometer at CES, an AI-powered, saliva-based hormone testing kit, enabling real-time at-home monitoring with precise multi-hormone analysis using a single-use cartridge.
In November 2023, the FDA approved Eli Lilly & Company's Zepbound (tirzepatide) injection, marking it as the first obesity treatment targeting both GIP and GLP-1 hormone receptors. Designed for adults with obesity or excess weight accompanied by related health conditions, Zepbound supports weight loss when combined with a calorie-restricted diet and regular physical activity.

Companies Covered in Endocrine Testing Market

Abbott Laboratories, Inc.
AB Sciex Pte. Ltd.
Agilent Technologies, Inc.
bioMerieux SA
Bio-Rad Laboratories Inc.
DiaSorin S.p.A.
F. Hoffmann-La Roche Ltd.
Laboratory Corporation of America Holdings (LabCorp)
Quest Diagnostics, Inc.
Thermo Fisher Scientific, Inc.
MP Biomedicals
Ortho-Clinical Diagnostics (QuidelOrtho Corporation)
Siemens Healthineers AG
Sysmex Corporation
Others

Frequently Asked Questions

The global market is estimated to increase from US$ 13.4 billion in 2025 to US$ 23.2 billion in 2032.

Rising endocrine disorders, technological advancements, automation, at-home testing, regulatory compliance, and expanding healthcare access drive market growth.

The market is projected to record a CAGR of 8.2% during the forecast period from 2025 to 2032.

Abbott Laboratories, AB Sciex, Agilent Technologies Inc, bioMerieux SA, Bio-Rad Laboratories Inc. and Others.

Opportunities include the expansion of point-of-care testing and AI-driven diagnostics unlock potential market opportunities.

Top-Down Market Sizing	Bottom-Up Market Sizing
Universe Definition: Total global/regional market identification	Unit Economics: Average transaction values, purchase frequencies, customer lifecycle
Segmentation Filters: Geographic, demographic, and behavioral constraints	Customer Segmentation: Detailed buyer persona development and sizing
Market Share Analysis: Competitive landscape assessment and share allocation	Penetration Analysis: Market penetration rates by segment and geography
Growth Rate Application: Historical trends and forward-looking growth assumptions	Scaling Methodology: Extrapolation techniques with confidence intervals

Interested in this report?

Request customization, ask for expert consulting, access a sample report, or simply express your interest—our team will assist you with the right insights and solutions.

Request Custom VersionRequest Custom Version

Clients

Media Citation

Get In Touch

Loading page data

Please wait a moment

Executive Summary
1. Global Endocrine Testing Market Snapshot, 2025 and 2032
2. Market Opportunity Assessment, 2025 - 2032, US$ Mn
3. Key Market Trends
4. Future Market Projections
5. Premium Market Insights
6. Industry Developments and Key Market Events
7. PMR Analysis and Recommendations
Market Overview
1. Market Scope and Definition
2. Market Dynamics
  1. Drivers
  2. Restraints
  3. Opportunity
  4. Challenges
  5. Key Trends
3. COVID-19 Impact Analysis
4. Forecast Factors - Relevance and Impact
Value Added Insights
1. Value Chain Analysis
2. Test Adoption / Usage Analysis
3. Government Initiatives & Funding in Endocrine Testing
4. Key Market Players
5. Regulatory Landscape
6. PESTLE Analysis
7. Porter’s Five Force Analysis
8. Consumer Behavior Analysis
Global Endocrine Testing Market Outlook
1. Key Highlights
  1. Market Size (US$ Mn) and Y-o-Y Growth
  2. Absolute $ Opportunity
2. Market Size (US$ Mn) Analysis and Forecast
  1. Historical Market Size (US$ Mn) Analysis, 2019-2024
  2. Current Market Size (US$ Mn) Analysis and Forecast, 2025-2032
3. Global Endocrine Testing Market Outlook: Test
  1. Historical Market Size (US$ Mn) Analysis, By Test, 2019-2024
  2. Current Market Size (US$ Mn) Analysis and Forecast, By Test, 2025-2032
    1. Testosterone Test
    2. Estradiol Test
    3. Thyroid Stimulating Hormone (TSH) Test
    4. Prolactin Test
    5. Luteinizing Hormone (LH) Test
    6. Progesterone Test
    7. Human Chorionic Gonadotropin (hCG) Hormone Test
    8. Insulin Test
    9. Others
  3. Market Attractiveness Analysis: Test
4. Global Endocrine Testing Market Outlook: Technology
  1. Historical Market Size (US$ Mn) Analysis, By Technology, 2019-2024
  2. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
    1. Tandem Mass Spectrometry
    2. Monoclonal & Polyclonal Antibody Technologies
    3. Clinical Chemistry
    4. Immunoassay
    5. Others
  3. Market Attractiveness Analysis: Technology
5. Global Endocrine Testing Market Outlook: Disease Indication
  1. Historical Market Size (US$ Mn) Analysis, By Disease Indication, 2019-2024
  2. Current Market Size (US$ Mn) Analysis and Forecast, By Disease Indication, 2025-2032
    1. Diabetes
    2. Hyperthyroidism
    3. Menopause
    4. Osteoporosis
    5. Cancer
    6. Others
  3. Market Attractiveness Analysis: Disease Indication
6. Global Endocrine Testing Market Outlook: End-use
  1. Historical Market Size (US$ Mn) Analysis, By End-use, 2019-2024
  2. Current Market Size (US$ Mn) Analysis and Forecast, By End-use, 2025-2032
    1. Hospitals
    2. Diagnotics Laboratories
    3. Ambulatory Care Centers
    4. Home-based Tests
    5. Speciality Centers
    6. Others
  3. Market Attractiveness Analysis: End-use
Global Endocrine Testing Market Outlook Region
1. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2024
2. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2025-2032
  1. North America
  2. Latin America
  3. Europe
  4. East Asia
  5. South Asia and Oceania
  6. Middle East & Africa
3. Market Attractiveness Analysis: Region
North America Endocrine Testing Market Outlook
1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  1. By Country
  2. By Test
  3. By Technology
  4. By Disease Indication
  5. By End-Use
2. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  1. U.S.
  2. Canada
3. Current Market Size (US$ Mn) Analysis and Forecast, By Test, 2025-2032
  1. Testosterone Test
  2. Estradiol Test
  3. Thyroid Stimulating Hormone (TSH) Test
  4. Prolactin Test
  5. Luteinizing Hormone (LH) Test
  6. Progesterone Test
  7. Human Chorionic Gonadotropin (hCG) Hormone Test
  8. Insulin Test
  9. Others
4. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
  1. Tandem Mass Spectrometry
  2. Monoclonal & Polyclonal Antibody Technologies
  3. Clinical Chemistry
  4. Immunoassay
  5. Others
5. Current Market Size (US$ Mn) Analysis and Forecast, By Disease Indication, 2025-2032
  1. Diabetes
  2. Hyperthyroidism
  3. Menopause
  4. Osteoporosis
  5. Cancer
  6. Others
6. Current Market Size (US$ Mn) Analysis and Forecast, By End-use, 2025-2032
  1. Hospitals
  2. Diagnotics Laboratories
  3. Ambulatory Care Centers
  4. Home-based Tests
  5. Speciality Centers
  6. Others
7. Market Attractiveness Analysis
Europe Endocrine Testing Market Outlook
1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  1. By Country
  2. By Test
  3. By Technology
  4. By Disease Indication
  5. By End-use
2. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  1. Germany
  2. France
  3. U.K.
  4. Italy
  5. Spain
  6. Russia
  7. Rest of Europe
3. Current Market Size (US$ Mn) Analysis and Forecast, By Test, 2025-2032
  1. Testosterone Test
  2. Estradiol Test
  3. Thyroid Stimulating Hormone (TSH) Test
  4. Prolactin Test
  5. Luteinizing Hormone (LH) Test
  6. Progesterone Test
  7. Human Chorionic Gonadotropin (hCG) Hormone Test
  8. Insulin Test
  9. Others
4. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
  1. Tandem Mass Spectrometry
  2. Monoclonal & Polyclonal Antibody Technologies
  3. Clinical Chemistry
  4. Immunoassay
  5. Others
5. Current Market Size (US$ Mn) Analysis and Forecast, By Disease Indication, 2025-2032
  1. Diabetes
  2. Hyperthyroidism
  3. Menopause
  4. Osteoporosis
  5. Cancer
  6. Others
6. Current Market Size (US$ Mn) Analysis and Forecast, By End-use, 2025-2032
  1. Hospitals
  2. Diagnotics Laboratories
  3. Ambulatory Care Centers
  4. Home-based Tests
  5. Speciality Centers
  6. Others
7. Market Attractiveness Analysis
East Asia Endocrine Testing Market Outlook
1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  1. By Country
  2. By Test
  3. By Disease Indication
  4. By End-Use
2. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  1. China
  2. Japan
  3. South Korea
3. Current Market Size (US$ Mn) Analysis and Forecast, By Test, 2025-2032
  1. Testosterone Test
  2. Estradiol Test
  3. Thyroid Stimulating Hormone (TSH) Test
  4. Prolactin Test
  5. Luteinizing Hormone (LH) Test
  6. Progesterone Test
  7. Human Chorionic Gonadotropin (hCG) Hormone Test
  8. Insulin Test
  9. Others
4. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
  1. Tandem Mass Spectrometry
  2. Monoclonal & Polyclonal Antibody Technologies
  3. Clinical Chemistry
  4. Immunoassay
  5. Others
5. Current Market Size (US$ Mn) Analysis and Forecast, By Disease Indication, 2025-2032
  1. Diabetes
  2. Hyperthyroidism
  3. Menopause
  4. Osteoporosis
  5. Cancer
  6. Others
6. Current Market Size (US$ Mn) Analysis and Forecast, By End-use, 2025-2032
  1. Hospitals
  2. Diagnotics Laboratories
  3. Ambulatory Care Centers
  4. Home-based Tests
  5. Speciality Centers
  6. Others
7. Market Attractiveness Analysis
South Asia & Oceania Endocrine Testing Market Outlook
1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  1. By Country
  2. By Test
  3. By Technology
  4. By Disease Indication
  5. By End-Use
2. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  1. India
  2. Indonesia
  3. Thailand
  4. Singapore
  5. ANZ
  6. Rest of South Asia & Oceania
3. Current Market Size (US$ Mn) Analysis and Forecast, By Test, 2025-2032
  1. Testosterone Test
  2. Estradiol Test
  3. Thyroid Stimulating Hormone (TSH) Test
  4. Prolactin Test
  5. Luteinizing Hormone (LH) Test
  6. Progesterone Test
  7. Human Chorionic Gonadotropin (hCG) Hormone Test
  8. Insulin Test
  9. Others
4. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
  1. Tandem Mass Spectrometry
  2. Monoclonal & Polyclonal Antibody Technologies
  3. Clinical Chemistry
  4. Immunoassay
  5. Others
5. Current Market Size (US$ Mn) Analysis and Forecast, By Disease Indication, 2025-2032
  1. Diabetes
  2. Hyperthyroidism
  3. Menopause
  4. Osteoporosis
  5. Cancer
  6. Others
6. Current Market Size (US$ Mn) Analysis and Forecast, By End-use, 2025-2032
  1. Hospitals
  2. Diagnotics Laboratories
  3. Ambulatory Care Centers
  4. Home-based Tests
  5. Speciality Centers
  6. Others
7. Market Attractiveness Analysis
Latin America Endocrine Testing Market Outlook
1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  1. By Country
  2. By Test
  3. BY Technology
  4. By Disease Indication
  5. By End-Use
2. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  1. Brazil
  2. Mexico
  3. Rest of Latin America
3. Current Market Size (US$ Mn) Analysis and Forecast, By Test, 2025-2032
  1. Testosterone Test
  2. Estradiol Test
  3. Thyroid Stimulating Hormone (TSH) Test
  4. Prolactin Test
  5. Luteinizing Hormone (LH) Test
  6. Progesterone Test
  7. Human Chorionic Gonadotropin (hCG) Hormone Test
  8. Insulin Test
  9. Others
4. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
  1. Tandem Mass Spectrometry
  2. Monoclonal & Polyclonal Antibody Technologies
  3. Clinical Chemistry
  4. Immunoassay
  5. Others
5. Current Market Size (US$ Mn) Analysis and Forecast, By Disease Indication, 2025-2032
  1. Diabetes
  2. Hyperthyroidism
  3. Menopause
  4. Osteoporosis
  5. Cancer
  6. Others
6. Current Market Size (US$ Mn) Analysis and Forecast, By End-use, 2025-2032
  1. Hospitals
  2. Diagnotics Laboratories
  3. Ambulatory Care Centers
  4. Home-based Tests
  5. Speciality Centers
  6. Others
7. Market Attractiveness Analysis
Middle East & Africa Endocrine Testing Market Outlook
1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  1. By Country
  2. By Test
  3. By Technology
  4. By Disease Indication
  5. By End-Use
2. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  1. GCC Countries
  2. Egypt
  3. South Africa
  4. Northern Africa
  5. Rest of Middle East & Africa
3. Current Market Size (US$ Mn) Analysis and Forecast, By Test, 2025-2032
  1. Testosterone Test
  2. Estradiol Test
  3. Thyroid Stimulating Hormone (TSH) Test
  4. Prolactin Test
  5. Luteinizing Hormone (LH) Test
  6. Progesterone Test
  7. Human Chorionic Gonadotropin (hCG) Hormone Test
  8. Insulin Test
  9. Others
4. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
  1. Tandem Mass Spectrometry
  2. Monoclonal & Polyclonal Antibody Technologies
  3. Clinical Chemistry
  4. Immunoassay
  5. Others
5. Current Market Size (US$ Mn) Analysis and Forecast, By Disease Indication, 2025-2032
  1. Diabetes
  2. Hyperthyroidism
  3. Menopause
  4. Osteoporosis
  5. Cancer
  6. Others
6. Current Market Size (US$ Mn) Analysis and Forecast, By End-use, 2025-2032
  1. Hospitals
  2. Diagnotics Laboratories
  3. Ambulatory Care Centers
  4. Home-based Tests
  5. Speciality Centers
  6. Others
7. Market Attractiveness Analysis
Competition Landscape
1. Market Share Analysis, 2025
2. Market Structure
  1. Competition Intensity Mapping by Market
  2. Competition Dashboard
3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  1. Abbott Laboratories, Inc.
    1. Overview
    2. Segments and Sources
    3. Key Financials
    4. Market Developments
    5. Market Strategy
  2. AB Sciex Pte. Ltd.
  3. Agilent Technologies, Inc.
  4. bioMerieux SA
  5. Bio-Rad Laboratories Inc.
  6. DiaSorin S.p.A.
  7. F. Hoffmann-La Roche Ltd.
  8. Laboratory Corporation of America Holdings (LabCorp)
  9. Quest Diagnostics, Inc.
  10. Thermo Fisher Scientific, Inc.
  11. MP Biomedicals
  12. Ortho-Clinical Diagnostics (QuidelOrtho Corporation)
  13. Siemens Healthineers AG
  14. Sysmex Corporation
  15. Others
Appendix
1. Research Methodology
2. Research Assumptions
3. Acronyms and Abbreviations

Global Market Attribute	Key Insights
Endocrine Testing Market Size (2025E)	US$ 13.4 Bn
Market Value Forecast (2032F)	US$ 23.2 Bn
Projected Growth (CAGR 2025 to 2032)	8.2%
Historical Market Growth (CAGR 2019 to 2024)	7.4%

Report Attribute	Details
Historical Data/Actuals	2019 - 2024
Forecast Period	2025 - 2032
Market Analysis Units	Value: US$ Bn, Volume: As applicable
Geographical Coverage	North America Europe East Asia South Asia and Oceania Middle East and Africa Latin America
Segmental Coverage	Test Technology Diseases Indication End-use Region
Competitive Analysis	Abbott Laboratories, Inc. AB Sciex Pte. Ltd. Agilent Technologies, Inc. bioMerieux SA Bio-Rad Laboratories Inc. DiaSorin S.p.A. F. Hoffmann-La Roche Ltd. Laboratory Corporation of America Holdings (LabCorp) Quest Diagnostics, Inc. Thermo Fisher Scientific, Inc. MP Biomedicals Ortho-Clinical Diagnostics (QuidelOrtho Corporation) Siemens Healthineers AG Sysmex Corporation Others
Report Highlights	Market Forecast and Trends Competitive Intelligence & Share Analysis Growth Factors and Challenges Strategic Growth Initiatives Future Opportunities and Revenue Pockets Industry Market Analysis Tools
Customization and Pricing	Available upon request

Global Market Attribute	Key Insights
Endocrine Testing Market Size (2025E)	US$ 13.4 Bn
Market Value Forecast (2032F)	US$ 23.2 Bn
Projected Growth (CAGR 2025 to 2032)	8.2%
Historical Market Growth (CAGR 2019 to 2024)	7.4%

Report Attribute	Details
Historical Data/Actuals	2019 - 2024
Forecast Period	2025 - 2032
Market Analysis Units	Value: US$ Bn, Volume: As applicable
Geographical Coverage	North America Europe East Asia South Asia and Oceania Middle East and Africa Latin America
Segmental Coverage	Test Technology Diseases Indication End-use Region
Competitive Analysis	Abbott Laboratories, Inc. AB Sciex Pte. Ltd. Agilent Technologies, Inc. bioMerieux SA Bio-Rad Laboratories Inc. DiaSorin S.p.A. F. Hoffmann-La Roche Ltd. Laboratory Corporation of America Holdings (LabCorp) Quest Diagnostics, Inc. Thermo Fisher Scientific, Inc. MP Biomedicals Ortho-Clinical Diagnostics (QuidelOrtho Corporation) Siemens Healthineers AG Sysmex Corporation Others
Report Highlights	Market Forecast and Trends Competitive Intelligence & Share Analysis Growth Factors and Challenges Strategic Growth Initiatives Future Opportunities and Revenue Pockets Industry Market Analysis Tools
Customization and Pricing	Available upon request

Endocrine Testing Market Size, Share, Trends, and Growth Forecast 2025 - 2032

Endocrine Testing Market by Test (Testosterone Test, Endocrine Test, Others), by Technology (Immunoassay, Tandem Mass Spectrometry, Others), by Disease Indication (Diabetes, Hyperthyroidism), by End-use, by Regional Analysis 2025 - 2032